Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Amolyt Pharma raised €130m in Series C funding co-led by Sofinnova Partners and Intermediate Capital Group

Amolyt Pharma raised €130m in Series C funding co-led by Sofinnova Partners and Intermediate Capital Group

Health services Pharma

Denmark

Sweden

France

United Kingdom

United States

Israel

Canada

Investments

06 January 2023

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Amolyt Pharma (company)

France

Health services Pharma

Total investments received (USD): 139.66M

Round value (USD): 139.66M

Round investors: Intermediate Capital Group Sofinnova Partners EQT Partners Novo A/S OrbiMed Advisors CTI Life Sciences Andera Partners Relyens Group Crédit Agricole Tekla Capital Management Turenne Capital Partenaires Pontifax Venture Capital

Company: Amolyt Pharma

Industry: Health services Pharma

Related deals

Waat raises €100M in an equity deal led by DWS, joined by RAISE Impact and Bpifrance

Automotive Energy Manufacturing Transportation

Germany

France

Investments 14 September 2025

Mistral raised series C €1.7 billion led by ASML in the Netherlands

AI (big data) Software Services

France

United Kingdom

Netherlands

United States

Russia

Investments 01 September 2025

Artbio in a $132 million Series B deal co-led by Sofinnova Investments and B Capital, joined by F-Prime, Omega Funds, and Third Rock Ventures.

Health services Manufacturing Pharma

Norway

France

United States

Qatar

Investments 05 July 2025

GlycoEra raised $130m in Series B led by Novo, joined by Catalio Capital, LifeArc Ventures, QIA, Sixty Degree Capital, Agent Capital, MP Healthcare, Sofinnova.

Biotech Health services Pharma

Denmark

Switzerland

France

United Kingdom

United States

Canada

Qatar

Investments 17 May 2025

Azafaros raised a €132M Series B financing led by Jeito Capital, co-led by Forbion Growth and joined by Seroba, Pictet Group, Schroders and BioGeneration.

Health services Manufacturing Pharma

Switzerland

France

United Kingdom

Ireland

Netherlands

Investments 02 May 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top